Nucor earnings beat by $0.08, revenue fell short of estimates
Investing.com - Pfizer reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Pfizer announced earnings per share of $0.72 on revenue of $12.13B. Analysts polled by Investing.com EPS of $0.69 on revenue of $12.31B.
Pfizer 's are down 3% and is trading at $37.92 , still down 7.44% from its 52 week high of $40.97 set on Friday, January 24, 2020.
Pfizer follows other major Healthcare sector earnings this month
Pfizer's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, EPS of $1.98 on revenue of $20.2B.
Novartis ADR had beat expectations on Tuesday with third quarter EPS of $1.52 on revenue of $12.26B, for EPS of $1.44 on revenue of $12.6B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar